MERIT is one of several metacognitive psychotherapies, designed especially to meet the needs of individuals living with serious mental illnesses, including schizophrenia. It is deliverable in both ...

Lund University provides funding as a member of The Conversation UK. What causes schizophrenia? This severe mental illness, which affects over 20 million people worldwide and is characterised by ...

Schizophrenia is a severe and debilitating psychiatric disorder that involves psychotic symptoms such as hallucinations and delusions, accompanied with regressive behaviour. Greater genetic ...

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential. University of ...

Get Instant Summarized Text (Gist) A new drug, JRT, derived from LSD, shows promise for treating schizophrenia by promoting neuroplasticity without causing hallucinations. By altering two atoms in ...

Scientists in Taiwan have used genome sequencing to demonstrate that men who become fathers later in life are more likely to pass on new genetic mutations that increase the risk of schizophrenia in ...

Schizophrenia can affect your life in many ways. It can impact your job, your relationships, and your finances. The large number of complications that come with schizophrenia make treatment so ...

Scientific literature has shown that patients with multiple sclerosis and schizophrenia lose myelin (called demyelination), leaving part of the axons "unplugged" and causing damage to brain function.

US-based pharmaceutical company Bristol Myers Squibb (BMS) has reported topline outcomes from the Phase III ARISE trial of Cobenfy as an adjunctive treatment to atypical antipsychotics for ...